JOHNSON & JOHNSON |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.4 EUR | -1.72% |
|
-0.07% | -3.46% |
| 07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
| 07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
25fc361475cc418de.MPNbkgFPsPnQMOryiDYV5U7XMk1fYkawuSxOvAH5BuY.caZj8G4piMDjR6bB0Bt_iwucACosDAH2iXp8y3GjcdVVvRnFdDjvkYlqow~73d8b2ef4c8a939d82c0d98b712ce41a
